BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, Mujagic Z, Jonkers DMAE, Masclee AAM, Fu J, Kurilshikov A, Wijmenga C, Zhernakova A, Weersma RK. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020;11:362. [PMID: 31953381 DOI: 10.1038/s41467-019-14177-z] [Cited by in Crossref: 103] [Cited by in F6Publishing: 191] [Article Influence: 51.5] [Reference Citation Analysis]
Number Citing Articles
1 Kyoung J, Atluri RR, Yang T. Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link? Hypertension 2022;79:2138-47. [PMID: 35862173 DOI: 10.1161/HYPERTENSIONAHA.122.19826] [Reference Citation Analysis]
2 de Lara-sánchez SS, Sánchez-pérez AM. Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review. JAD 2022. [DOI: 10.3233/jad-220615] [Reference Citation Analysis]
3 Franklin F, Rajamanikam A, Raju CS, Gill JS, Francis B, Sy-Cherng LW, Kumar S. Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients. Parasit Vectors 2022;15:313. [PMID: 36064639 DOI: 10.1186/s13071-022-05418-0] [Reference Citation Analysis]
4 Chen YC, Lin HY, Chien Y, Tung YH, Ni YH, Gau SS. Altered gut microbiota correlates with behavioral problems but not gastrointestinal symptoms in individuals with autism. Brain Behav Immun 2022:S0889-1591(22)00371-3. [PMID: 36058421 DOI: 10.1016/j.bbi.2022.08.015] [Reference Citation Analysis]
5 Swarte JC, Li Y, Hu S, Björk JR, Gacesa R, Vich Vila A, Douwes RM, Collij V, Kurilshikov A, Post A, Klaassen MAY, Eisenga MF, Gomes-Neto AW, Kremer D, Jansen BH, Knobbe TJ, Berger SP, Sanders JF, Heiner-Fokkema MR, Porte RJ, Cuperus FJC, de Meijer VE, Wijmenga C, Festen EAM, Zhernakova A, Fu J, Harmsen HJM, Blokzijl H, Bakker SJL, Weersma RK. Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation. Sci Transl Med 2022;14:eabn7566. [PMID: 36044594 DOI: 10.1126/scitranslmed.abn7566] [Reference Citation Analysis]
6 Wu J, Peng Z, Wu Q, Tang RWL, Dong T, Wang H, Tsim KWK. The water extract of Aloe vera prevents fluoxetine-induced multiple-drug resistance of E. coli by inhibiting reactive oxygen species formation and membrane permeability. Phytomedicine 2022;106:154421. [PMID: 36054995 DOI: 10.1016/j.phymed.2022.154421] [Reference Citation Analysis]
7 Rathour D, Shah S, Khan S, Singh PK, Srivastava S, Singh SB, Khatri DK. ROLE OF GUT MICROBIOTA IN DEPRESSION: UNDERSTANDING MOLECULAR PATHWAYS, RECENT RESEARCH, AND FUTURE DIRECTION. Behav Brain Res 2022;:114081. [PMID: 36037843 DOI: 10.1016/j.bbr.2022.114081] [Reference Citation Analysis]
8 Ettinger S. Diet, Gut Microbiome, and Cognitive Decline. Curr Nutr Rep 2022. [PMID: 36018501 DOI: 10.1007/s13668-022-00435-y] [Reference Citation Analysis]
9 Hasavci D, Blank T. Age-dependent effects of gut microbiota metabolites on brain resident macrophages. Front Cell Neurosci 2022;16:944526. [DOI: 10.3389/fncel.2022.944526] [Reference Citation Analysis]
10 Pravda J. Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide. World J Gastroenterol 2022; 28(31): 4263-4298 [DOI: 10.3748/wjg.v28.i31.4263] [Reference Citation Analysis]
11 Lavi I, Gronich N. Serum cholesterol increase in statin users associated with antibiotic use: Case-crossover study. Eur J Pharmacol 2022;:175209. [PMID: 35987256 DOI: 10.1016/j.ejphar.2022.175209] [Reference Citation Analysis]
12 Silva AR, Bernardo A, de Mesquita MF, Vaz-patto J, Moreira P, Silva ML, Padrão P. An anti-inflammatory and low fermentable oligo, di, and monosaccharides and polyols diet improved patient reported outcomes in fibromyalgia: A randomized controlled trial. Front Nutr 2022;9:856216. [DOI: 10.3389/fnut.2022.856216] [Reference Citation Analysis]
13 Liu L, Zhang J, Cheng Y, Zhu M, Xiao Z, Ruan G, Wei Y. Gut microbiota: A new target for T2DM prevention and treatment. Front Endocrinol 2022;13:958218. [DOI: 10.3389/fendo.2022.958218] [Reference Citation Analysis]
14 Liu N, Liu J, Wang H, Li S, Zhang W. Microbes team with nanoscale zero-valent iron: A robust route for degradation of recalcitrant pollutants. Journal of Environmental Sciences 2022;118:140-6. [DOI: 10.1016/j.jes.2021.12.037] [Reference Citation Analysis]
15 Storm-Larsen C, Hande LN, Kummen M, Thunhaug H, Vestad B, Hansen SH, Hovland A, Trøseid M, Lappegård KT, Hov JR. Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial. Scand J Clin Lab Invest 2022;:1-8. [PMID: 35913798 DOI: 10.1080/00365513.2022.2102540] [Reference Citation Analysis]
16 Cox TO, Lundgren P, Nath K, Thaiss CA. Metabolic control by the microbiome. Genome Med 2022;14:80. [PMID: 35906678 DOI: 10.1186/s13073-022-01092-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peiffer LB, White JR, Jones CB, Slottke RE, Ernst SE, Moran AE, Graff JN, Sfanos KS. Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab). Neoplasia 2022;32:100822. [PMID: 35908379 DOI: 10.1016/j.neo.2022.100822] [Reference Citation Analysis]
18 Pant A, Maiti TK, Mahajan D, Das B. Human Gut Microbiota and Drug Metabolism. Microb Ecol. [DOI: 10.1007/s00248-022-02081-x] [Reference Citation Analysis]
19 Dong Z, Shen X, Hao Y, Li J, Xu H, Yin L, Kuang W. Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder. Front Neurosci 2022;16:813075. [DOI: 10.3389/fnins.2022.813075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lesniak NA, Schubert AM, Flynn KJ, Leslie JL, Sinani H, Bergin IL, Young VB, Schloss PD. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity. mBio 2022;:e0118322. [PMID: 35856563 DOI: 10.1128/mbio.01183-22] [Reference Citation Analysis]
21 Barone M, D'Amico F, Rampelli S, Brigidi P, Turroni S. Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging. Mech Ageing Dev 2022;206:111711. [PMID: 35868543 DOI: 10.1016/j.mad.2022.111711] [Reference Citation Analysis]
22 Parker A, James SA, Purse C, Brion A, Goldson A, Telatin A, Baker D, Carding SR. Absence of Bacteria Permits Fungal Gut-To-Brain Translocation and Invasion in Germfree Mice but Ageing Alone Does Not Drive Pathobiont Expansion in Conventionally Raised Mice. Front Aging Neurosci 2022;14:828429. [DOI: 10.3389/fnagi.2022.828429] [Reference Citation Analysis]
23 Martinez E, Taminiau B, Rodriguez C, Daube G. Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection. Pathogens 2022;11:781. [PMID: 35890026 DOI: 10.3390/pathogens11070781] [Reference Citation Analysis]
24 Zhao F, Wang K, Wen Y, Chen X, Liu H, Qi F, Fu Y, Zhu J, Guan S, Liu Z. Contribution of hippocampal BDNF/CREB signaling pathway and gut microbiota to emotional behavior impairment induced by chronic unpredictable mild stress during pregnancy in rats offspring. PeerJ 2022;10:e13605. [PMID: 35769142 DOI: 10.7717/peerj.13605] [Reference Citation Analysis]
25 Li Z, Zhou J, Liang H, Ye L, Lan L, Lu F, Wang Q, Lei T, Yang X, Cui P, Huang J. Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases. Front Neurosci 2022;16:879318. [DOI: 10.3389/fnins.2022.879318] [Reference Citation Analysis]
26 Rahman MM, Islam F, -Or-Rashid MH, Mamun AA, Rahaman MS, Islam MM, Meem AFK, Sutradhar PR, Mitra S, Mimi AA, Emran TB, Fatimawali, Idroes R, Tallei TE, Ahmed M, Cavalu S. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front Cell Infect Microbiol 2022;12:903570. [DOI: 10.3389/fcimb.2022.903570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
27 St-Laurent T, Hammami R. The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis. Nutrients 2022;14:2523. [PMID: 35745252 DOI: 10.3390/nu14122523] [Reference Citation Analysis]
28 Rashed R, Valcheva R, Dieleman LA. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease. Front Med 2022;9:887044. [DOI: 10.3389/fmed.2022.887044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Argentini C, Mancabelli L, Alessandri G, Tarracchini C, Barbetti M, Carnevali L, Longhi G, Viappiani A, Anzalone R, Milani C, Sgoifo A, van Sinderen D, Ventura M, Turroni F. Exploring the Ecological Effects of Naturally Antibiotic-Insensitive Bifidobacteria in the Recovery of the Resilience of the Gut Microbiota during and after Antibiotic Treatment. Appl Environ Microbiol 2022;:e0052222. [PMID: 35652662 DOI: 10.1128/aem.00522-22] [Reference Citation Analysis]
30 Lee JH, Park JH. Host-microbial interactions in metabolic diseases: from diet to immunity. J Microbiol 2022;60:561-75. [PMID: 35511325 DOI: 10.1007/s12275-022-2087-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Staudacher HM, Yao CK, Chey WD, Whelan K. Optimal Design of Clinical Trials of Dietary Interventions in Disorders of Gut-Brain Interaction. Am J Gastroenterol 2022;117:973-84. [PMID: 35297784 DOI: 10.14309/ajg.0000000000001732] [Reference Citation Analysis]
32 Karczewski J, Zielińska A, Staszewski R, Eder P, Dobrowolska A, Souto EB. Obesity and the Brain. Int J Mol Sci 2022;23:6145. [PMID: 35682824 DOI: 10.3390/ijms23116145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
33 Khalikov AA, Kildyushov EM, Kuznetsov KO, Rahmatullina GR. [Estimation of time since death with the postmortem microbiome: a modern view and approaches to solving the problem]. Sud Med Ekspert 2022;65:49-53. [PMID: 35613449 DOI: 10.17116/sudmed20226503149] [Reference Citation Analysis]
34 Bae SS, Dong TS, Wang J, Lagishetty V, Katzka W, Jacobs JP, Charles-Schoeman C. Altered Gut Microbiome in Patients With Dermatomyositis. ACR Open Rheumatol 2022. [PMID: 35615912 DOI: 10.1002/acr2.11436] [Reference Citation Analysis]
35 Guo W, Mao B, Cui S, Tang X, Zhang Q, Zhao J, Zhang H. Protective Effects of a Novel Probiotic Bifidobacterium pseudolongum on the Intestinal Barrier of Colitis Mice via Modulating the Pparγ/STAT3 Pathway and Intestinal Microbiota. Foods 2022;11:1551. [DOI: 10.3390/foods11111551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Eltokhi A, Sommer IE. A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics? Front Neurosci 2022;16:852506. [PMID: 35546876 DOI: 10.3389/fnins.2022.852506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Chen Y, Wang X, Zhang C, Liu Z, Li C, Ren Z. Gut Microbiota and Bone Diseases: A Growing Partnership. Front Microbiol 2022;13:877776. [DOI: 10.3389/fmicb.2022.877776] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Shandilya S, Kumar S, Kumar Jha N, Kumar Kesari K, Ruokolainen J. Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection. Journal of Advanced Research 2022;38:223-44. [DOI: 10.1016/j.jare.2021.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
39 Chakaroun R, Massier L, Musat N, Kovacs P. New Paradigms for Familiar Diseases: Lessons Learned on Circulatory Bacterial Signatures in Cardiometabolic Diseases. Exp Clin Endocrinol Diabetes 2022;130:313-26. [PMID: 35320847 DOI: 10.1055/a-1756-4509] [Reference Citation Analysis]
40 Mitrea L, Nemeş SA, Szabo K, Teleky BE, Vodnar DC. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Front Med (Lausanne) 2022;9:813204. [PMID: 35433746 DOI: 10.3389/fmed.2022.813204] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
41 Ramos CP, Kamei CYI, Viegas FM, de Melo Barbieri J, Cunha JLR, Hounmanou YMG, Coura FM, Santana JA, Lobato FCF, Bojesen AM, Silva ROS. Fecal Shedding of Multidrug Resistant Escherichia coli Isolates in Dogs Fed with Raw Meat-Based Diets in Brazil. Antibiotics 2022;11:534. [DOI: 10.3390/antibiotics11040534] [Reference Citation Analysis]
42 Russo GI, Bongiorno D, Bonomo C, Musso N, Stefani S, Sokolakis I, Hatzichristodolou G, Falcone M, Cai T, Smarrazzo F, Verze P; EAU-YAU Sexual and Reproductive Health Group. The relationship between the gut microbiota, benign prostatic hyperplasia, and erectile dysfunction. Int J Impot Res 2022. [PMID: 35418604 DOI: 10.1038/s41443-022-00569-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Cronin P, Murphy CL, Barrett M, Ghosh TS, Pellanda P, O'Connor EM, Zulquernain SA, Kileen S, McCourt M, Andrews E, O'Riordain MG, Shanahan F, O'Toole PW. Colorectal microbiota after removal of colorectal cancer. NAR Cancer 2022;4:zcac011. [PMID: 35399186 DOI: 10.1093/narcan/zcac011] [Reference Citation Analysis]
44 Fu S, Lee C, Hsieh Y, Wu P, Lin S, Wang H. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease. Front Cell Infect Microbiol 2022;12:837019. [DOI: 10.3389/fcimb.2022.837019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Barron MR, Young VB. Viewing Bacterial Colonization through the Lens of Systems Biology. mSystems 2022;:e0138321. [PMID: 35354321 DOI: 10.1128/msystems.01383-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Dong Y, Wang P, Jiao J, Yang X, Chen M, Li J. Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients. Front Cell Dev Biol 2022;10:861829. [DOI: 10.3389/fcell.2022.861829] [Reference Citation Analysis]
47 Manchia M, Squassina A, Tozzi F, Antoniades A, Carpiniello B. Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers. Pharmacogenomics 2022. [PMID: 35238627 DOI: 10.2217/pgs-2022-0018] [Reference Citation Analysis]
48 Shoubridge AP, Choo JM, Martin AM, Keating DJ, Wong ML, Licinio J, Rogers GB. The gut microbiome and mental health: advances in research and emerging priorities. Mol Psychiatry 2022. [PMID: 35236957 DOI: 10.1038/s41380-022-01479-w] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Trujillo-del Río C, Tortajada-pérez J, Gómez-escribano A, Casterá F, Peiró C, Millán J, Herrero M, Vázquez-manrique R. Metformin to treat Huntington disease: a pleiotropic drug against a multi-system disorder. Mechanisms of Ageing and Development 2022. [DOI: 10.1016/j.mad.2022.111670] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lin TL, Wu CY, Fan YH, Chang YL, Ho HJ, Chen YJ. Association between early life laxative exposure and risk of allergic diseases A nationwide matched cohort study. Ann Allergy Asthma Immunol 2022;128:291-298.e3. [PMID: 34998978 DOI: 10.1016/j.anai.2021.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Tamburini FB, Maghini D, Oduaran OH, Brewster R, Hulley MR, Sahibdeen V, Norris SA, Tollman S, Kahn K, Wagner RG, Wade AN, Wafawanaka F, Gómez-Olivé FX, Twine R, Lombard Z, Hazelhurst S, Bhatt AS; H3Africa AWI-Gen Collaborative Centre. Short- and long-read metagenomics of urban and rural South African gut microbiomes reveal a transitional composition and undescribed taxa. Nat Commun 2022;13:926. [PMID: 35194028 DOI: 10.1038/s41467-021-27917-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
52 Bikov A, Szabo H, Piroska M, Kunos L, Szily M, Ligeti B, Makra N, Szabo D, Tarnoki DL, Tarnoki AD. Gut Microbiome in Patients with Obstructive Sleep Apnoea. Applied Sciences 2022;12:2007. [DOI: 10.3390/app12042007] [Reference Citation Analysis]
53 König RS, Albrich WC, Kahlert CR, Bahr LS, Löber U, Vernazza P, Scheibenbogen C, Forslund SK. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Front Immunol 2021;12:628741. [PMID: 35046929 DOI: 10.3389/fimmu.2021.628741] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
54 Aasmets O, Krigul KL, Lüll K, Metspalu A, Org E. Gut metagenome associations with extensive digital health data in a volunteer-based Estonian microbiome cohort. Nat Commun 2022;13:869. [PMID: 35169130 DOI: 10.1038/s41467-022-28464-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Mousa WK, Chehadeh F, Husband S. Recent Advances in Understanding the Structure and Function of the Human Microbiome. Front Microbiol 2022;13:825338. [DOI: 10.3389/fmicb.2022.825338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
56 Lindell AE, Zimmermann-kogadeeva M, Patil KR. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat Rev Microbiol. [DOI: 10.1038/s41579-022-00681-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
57 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
58 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Takahara M, Takaki A, Hiraoka S, Takei K, Yasutomi E, Igawa S, Yamamoto S, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Udono H, Okada H. Metformin ameliorates chronic colitis in a mouse model by regulating interferon‐γ‐producing lamina propria CD4 + T cells through AMPK activation. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202100831rr] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Mukherjee S, Skrede S, Milbank E, Andriantsitohaina R, López M, Fernø J. Understanding the Effects of Antipsychotics on Appetite Control. Front Nutr 2021;8:815456. [PMID: 35047549 DOI: 10.3389/fnut.2021.815456] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 Zhang W, Wang T, Guo R, Cui W, Yu W, Wang Z, Jiang Y, Jiang M, Wang X, Liu C, Xiao J, Shang J, Wen X, Zhao Z. Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus. Front Cell Infect Microbiol 2022;11:761757. [DOI: 10.3389/fcimb.2021.761757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
62 Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-zamora A, Mai V, Vedam-mai V. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci 2022;13:782082. [DOI: 10.3389/fnagi.2021.782082] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
63 Markulin I, Matasin M, Turk VE, Salković-Petrisic M. Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease. J Neural Transm (Vienna) 2022. [PMID: 34982206 DOI: 10.1007/s00702-021-02457-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Mujagic Z, Kasapi M, Jonkers DM, Garcia-Perez I, Vork L, Weerts ZZRM, Serrano-Contreras JI, Zhernakova A, Kurilshikov A, Scotcher J, Holmes E, Wijmenga C, Keszthelyi D, Nicholson JK, Posma JM, Masclee AA. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes 2022;14:2063016. [PMID: 35446234 DOI: 10.1080/19490976.2022.2063016] [Reference Citation Analysis]
65 Ditmer M, Gabryelska A, Turkiewicz S, Białasiewicz P, Małecka-Wojciesko E, Sochal M. Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review. J Clin Med 2021;11:67. [PMID: 35011807 DOI: 10.3390/jcm11010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Walker RL, Vlamakis H, Lee JWJ, Besse LA, Xanthakis V, Vasan RS, Shaw SY, Xavier RJ. Population study of the gut microbiome: associations with diet, lifestyle, and cardiometabolic disease. Genome Med 2021;13:188. [PMID: 34915914 DOI: 10.1186/s13073-021-01007-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
67 DeClercq V, Nearing JT, Langille MGI. Investigation of the impact of commonly used medications on the oral microbiome of individuals living without major chronic conditions. PLoS One 2021;16:e0261032. [PMID: 34882708 DOI: 10.1371/journal.pone.0261032] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Forslund SK, Chakaroun R, Zimmermann-Kogadeeva M, Markó L, Aron-Wisnewsky J, Nielsen T, Moitinho-Silva L, Schmidt TSB, Falony G, Vieira-Silva S, Adriouch S, Alves RJ, Assmann K, Bastard JP, Birkner T, Caesar R, Chilloux J, Coelho LP, Fezeu L, Galleron N, Helft G, Isnard R, Ji B, Kuhn M, Le Chatelier E, Myridakis A, Olsson L, Pons N, Prifti E, Quinquis B, Roume H, Salem JE, Sokolovska N, Tremaroli V, Valles-Colomer M, Lewinter C, Søndertoft NB, Pedersen HK, Hansen TH, Gøtze JP, Køber L, Vestergaard H, Hansen T, Zucker JD, Hercberg S, Oppert JM, Letunic I, Nielsen J, Bäckhed F, Ehrlich SD, Dumas ME, Raes J, Pedersen O, Clément K, Stumvoll M, Bork P; MetaCardis Consortium*. Combinatorial, additive and dose-dependent drug-microbiome associations. Nature 2021;600:500-5. [PMID: 34880489 DOI: 10.1038/s41586-021-04177-9] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
69 Nycz J, Zajdel A. Mikrobiota jelitowa a leki. Interakcje wpływające na skuteczność i bezpieczeństwo farmakoterapii. Postępy Higieny i Medycyny Doświadczalnej 2021;75:762-72. [DOI: 10.2478/ahem-2021-0009] [Reference Citation Analysis]
70 Verschueren MV, van der Welle CMC, Tonn M, Schramel FMNH, Peters BJM, van de Garde EMW. The association between gut microbiome affecting concomitant medication and the effectiveness of immunotherapy in patients with stage IV NSCLC. Sci Rep 2021;11:23331. [PMID: 34857829 DOI: 10.1038/s41598-021-02598-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Gröbner EM, Zeiler M, Fischmeister FPS, Kollndorfer K, Schmelz S, Schneider A, Haid-Stecher N, Sevecke K, Wagner G, Keller L, Adan R, Danner U, van Elburg A, van der Vijgh B, Kooij KL, Fetissov S, Andreani NA, Baines JF, Dempfle A, Seitz J, Herpertz-Dahlmann B, Karwautz A. The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa-A study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial. Eur Eat Disord Rev 2022;30:61-74. [PMID: 34851002 DOI: 10.1002/erv.2876] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
72 Si J, Lee G, You HJ, Joo SK, Lee DH, Ku BJ, Park S, Kim W, Ko G. Gut microbiome signatures distinguish type 2 diabetes mellitus from non-alcoholic fatty liver disease. Comput Struct Biotechnol J 2021;19:5920-30. [PMID: 34849196 DOI: 10.1016/j.csbj.2021.10.032] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
73 Belas A, Correia J, Marques C, da Gama LT, Pomba C. ESBL/AmpC-Producing Enterobacteriaceae Fecal Colonization in Dogs after Elective Surgery. Microbiology Research 2021;12:907-15. [DOI: 10.3390/microbiolres12040067] [Reference Citation Analysis]
74 Strisciuglio C, Coppola V, Russo M, Tolone C, Marseglia GL, Verrotti A, Caimmi S, Caloisi C, D'Argenio V, Sacchetti L, Staiano A. Promelaxin Microenemas Are Non-inferior to Oral Polyethylene Glycol for the Treatment of Functional Constipation in Young Children: A Randomized Clinical Trial. Front Pediatr 2021;9:753938. [PMID: 34778144 DOI: 10.3389/fped.2021.753938] [Reference Citation Analysis]
75 Tomkovich S, Taylor A, King J, Colovas J, Bishop L, McBride K, Royzenblat S, Lesniak NA, Bergin IL, Schloss PD. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance. mSphere 2021;6:e0062921. [PMID: 34585964 DOI: 10.1128/mSphere.00629-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Al Kassaa I, El Omari S, Abbas N, Papon N, Drider D, Kassem II, Osman M. High association of COVID-19 severity with poor gut health score in Lebanese patients. PLoS One 2021;16:e0258913. [PMID: 34673813 DOI: 10.1371/journal.pone.0258913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Schlender J, Behrens F, McParland V, Müller D, Wilck N, Bartolomaeus H, Holle J. Bacterial metabolites and cardiovascular risk in children with chronic kidney disease. Mol Cell Pediatr 2021;8:17. [PMID: 34677718 DOI: 10.1186/s40348-021-00126-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Skarpengland T, Macpherson ME, Hov JR, Kong XY, Bohov P, Halvorsen B, Fevang B, Berge RK, Aukrust P, Jørgensen SF. Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency. J Clin Immunol 2021. [PMID: 34669143 DOI: 10.1007/s10875-021-01146-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
79 Foster JA, Baker GB, Dursun SM. The Relationship Between the Gut Microbiome-Immune System-Brain Axis and Major Depressive Disorder. Front Neurol 2021;12:721126. [PMID: 34650506 DOI: 10.3389/fneur.2021.721126] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
80 Sultan S, El-Mowafy M, Elgaml A, Ahmed TAE, Hassan H, Mottawea W. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease. Front Physiol 2021;12:715506. [PMID: 34646151 DOI: 10.3389/fphys.2021.715506] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
81 Maier L, Goemans CV, Wirbel J, Kuhn M, Eberl C, Pruteanu M, Müller P, Garcia-Santamarina S, Cacace E, Zhang B, Gekeler C, Banerjee T, Anderson EE, Milanese A, Löber U, Forslund SK, Patil KR, Zimmermann M, Stecher B, Zeller G, Bork P, Typas A. Unravelling the collateral damage of antibiotics on gut bacteria. Nature 2021;599:120-4. [PMID: 34646011 DOI: 10.1038/s41586-021-03986-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
82 Kaczmarczyk O, Dąbek-Drobny A, Woźniakiewicz M, Paśko P, Dobrowolska-Iwanek J, Woźniakiewicz A, Piątek-Guziewicz A, Zagrodzki P, Mach T, Zwolińska-Wcisło M. Fecal Levels of Lactic, Succinic and Short-Chain Fatty Acids in Patients with Ulcerative Colitis and Crohn Disease: A Pilot Study. J Clin Med 2021;10:4701. [PMID: 34682823 DOI: 10.3390/jcm10204701] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
83 Shi J, Yang Y, Xu W, Cai H, Wu J, Long J, Cai Q, Zheng W, Flynn CR, Shu XO, Yu D. Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults. Microorganisms 2021;9:2118. [PMID: 34683439 DOI: 10.3390/microorganisms9102118] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
84 Mishima Y, Ishihara S. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome. Int J Mol Sci 2021;22:10235. [PMID: 34638577 DOI: 10.3390/ijms221910235] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
85 Willems RPJ, van Dijk K, Dierikx CM, Twisk JWR, van der Klis FRM, de Greeff SC, Vandenbroucke-Grauls CMJE. Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study. J Antimicrob Chemother 2021:dkab345. [PMID: 34550358 DOI: 10.1093/jac/dkab345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Wu J, Bortolanza M, Zhai G, Shang A, Ling Z, Jiang B, Shen X, Yao Y, Yu J, Li L, Cao H. Gut microbiota dysbiosis associated with plasma levels of Interferon-γ and viral load in patients with acute hepatitis E infection. J Med Virol 2022;94:692-702. [PMID: 34549810 DOI: 10.1002/jmv.27356] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
87 Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol 2021. [PMID: 34552265 DOI: 10.1038/s41579-021-00621-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
88 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
89 Balvers M, Deschasaux M, van den Born BJ, Zwinderman K, Nieuwdorp M, Levin E. Analyzing Type 2 Diabetes Associations with the Gut Microbiome in Individuals from Two Ethnic Backgrounds Living in the Same Geographic Area. Nutrients 2021;13:3289. [PMID: 34579166 DOI: 10.3390/nu13093289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
90 Xiang Y, Wong KC, So HC. Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities. Pharmaceutics 2021;13:1514. [PMID: 34575590 DOI: 10.3390/pharmaceutics13091514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM 3rd, Sung J. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med 2021;13:149. [PMID: 34517888 DOI: 10.1186/s13073-021-00957-0] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
92 Nogal B, Blumberg JB, Blander G, Jorge M. Gut Microbiota-Informed Precision Nutrition in the Generally Healthy Individual: Are We There Yet? Curr Dev Nutr 2021;5:nzab107. [PMID: 34514287 DOI: 10.1093/cdn/nzab107] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Aydin S, Ozkul C, Yucel NT, Karaca H. Gut Microbiome Alteration after Reboxetine Administration in Type-1 Diabetic Rats. Microorganisms 2021;9:1948. [PMID: 34576843 DOI: 10.3390/microorganisms9091948] [Reference Citation Analysis]
94 Straube J, Lane SW, Vu T. Optimizing DNA hypomethylating therapy in acute myeloid leukemia and myelodysplastic syndromes. Bioessays 2021;43:e2100125. [PMID: 34463368 DOI: 10.1002/bies.202100125] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Seely KD, Kotelko CA, Douglas H, Bealer B, Brooks AE. The Human Gut Microbiota: A Key Mediator of Osteoporosis and Osteogenesis. Int J Mol Sci 2021;22:9452. [PMID: 34502371 DOI: 10.3390/ijms22179452] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
96 Shi Y, Cai H, Niu Z, Li J, Pan G, Tian H, Wei L, Chen L, Yang P, Wang J, Cao H, Gao L. Acute oral colchicine caused gastric mucosal injury and disturbance of associated microbiota in mice. Toxicology 2021;461:152908. [PMID: 34453961 DOI: 10.1016/j.tox.2021.152908] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Dietert RR. Microbiome First Medicine in Health and Safety. Biomedicines 2021;9:1099. [PMID: 34572284 DOI: 10.3390/biomedicines9091099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Stiller A, Garrison K, Gurdyumov K, Kenner J, Yasmin F, Yates P, Song BH. From Fighting Critters to Saving Lives: Polyphenols in Plant Defense and Human Health. Int J Mol Sci 2021;22:8995. [PMID: 34445697 DOI: 10.3390/ijms22168995] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
99 Read E, Curtis MA, Neves JF. The role of oral bacteria in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18:731-42. [PMID: 34400822 DOI: 10.1038/s41575-021-00488-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
100 d'Enfert C, Kaune AK, Alaban LR, Chakraborty S, Cole N, Delavy M, Kosmala D, Marsaux B, Fróis-Martins R, Morelli M, Rosati D, Valentine M, Xie Z, Emritloll Y, Warn PA, Bequet F, Bougnoux ME, Bornes S, Gresnigt MS, Hube B, Jacobsen ID, Legrand M, Leibundgut-Landmann S, Manichanh C, Munro CA, Netea MG, Queiroz K, Roget K, Thomas V, Thoral C, Van den Abbeele P, Walker AW, Brown AJP. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev 2021;45:fuaa060. [PMID: 33232448 DOI: 10.1093/femsre/fuaa060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
101 Totzeck A, Ramakrishnan E, Schlag M, Stolte B, Kizina K, Bolz S, Thimm A, Stettner M, Marchesi JR, Buer J, Kleinschnitz C, Verhasselt HL, Hagenacker T. Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study. Ther Adv Neurol Disord 2021;14:17562864211035657. [PMID: 34394728 DOI: 10.1177/17562864211035657] [Reference Citation Analysis]
102 Rogers CC, Moutinho TJ Jr, Liu X, Valdez RS. Designing Consumer Health Information Technology to Support Biform and Articulation Work: A Qualitative Study of Diet and Nutrition Management as Patient Work. JMIR Hum Factors 2021;8:e27452. [PMID: 34383664 DOI: 10.2196/27452] [Reference Citation Analysis]
103 Rittig N, Aagaard NK, Sundelin E, Villadsen GE, Sandahl TD, Holst JJ, Hartmann B, Brøsen K, Grønbaek H, Jessen N. Metformin Stimulates Intestinal Glycolysis and Lactate Release: A single-Dose Study of Metformin in Patients With Intrahepatic Portosystemic Stent. Clin Pharmacol Ther 2021. [PMID: 34331316 DOI: 10.1002/cpt.2382] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
104 Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K. Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial. EBioMedicine 2021;70:103511. [PMID: 34329947 DOI: 10.1016/j.ebiom.2021.103511] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Maksimaityte V, Bausys A, Kryzauskas M, Luksta M, Stundiene I, Bickaite K, Bausys B, Poskus T, Bausys R, Strupas K. Gastrectomy impact on the gut microbiome in patients with gastric cancer: A comprehensive review. World J Gastrointest Surg 2021; 13(7): 678-688 [PMID: 34354801 DOI: 10.4240/wjgs.v13.i7.678] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Fried S, Wemelle E, Cani PD, Knauf C. Interactions between the microbiota and enteric nervous system during gut-brain disorders. Neuropharmacology 2021;197:108721. [PMID: 34274348 DOI: 10.1016/j.neuropharm.2021.108721] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
107 Le Bastard Q, Berthelot L, Soulillou JP, Montassier E. Impact of non-antibiotic drugs on the human intestinal microbiome. Expert Rev Mol Diagn 2021;:1-14. [PMID: 34225544 DOI: 10.1080/14737159.2021.1952075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
108 Beale AL, O'Donnell JA, Nakai ME, Nanayakkara S, Vizi D, Carter K, Dean E, Ribeiro RV, Yiallourou S, Carrington MJ, Marques FZ, Kaye DM. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 2021;10:e020654. [PMID: 34212778 DOI: 10.1161/JAHA.120.020654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
109 Karakuła KH, Padała O, Ryczkowski A, Forma A, Juchnowicz D. Controversies involving the use of SSRIs during pregnancy and the increased risk of having a child with autism spectrum disorders – a case report and literature review. Current Problems of Psychiatry 2020;21:269-87. [DOI: 10.2478/cpp-2020-0023] [Reference Citation Analysis]
110 Zhang X, Han Y, Huang W, Jin M, Gao Z. The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharm Sin B 2021;11:1789-812. [PMID: 34386321 DOI: 10.1016/j.apsb.2020.09.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 18.0] [Reference Citation Analysis]
111 Chen J, Vitetta L. Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19. J Clin Med 2021;10:2903. [PMID: 34209870 DOI: 10.3390/jcm10132903] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
112 Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Stagg AJ, Lindsay JO, Whelan K. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease. Clin Nutr 2021;40:5009-19. [PMID: 34364241 DOI: 10.1016/j.clnu.2021.05.033] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
113 Li J, Morrow C, Barnes S, Wilson L, Womack ED, McLain A, Yarar-Fisher C. Gut microbiome composition and serum metabolome profile among individuals with spinal cord injury and normal glucose tolerance or prediabetes/type 2 diabetes. Arch Phys Med Rehabil 2021:S0003-9993(21)00438-X. [PMID: 34126067 DOI: 10.1016/j.apmr.2021.03.043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
114 Sanders DJ, Inniss S, Sebepos-Rogers G, Rahman FZ, Smith AM. The role of the microbiome in gastrointestinal inflammation. Biosci Rep 2021;41:BSR20203850. [PMID: 34076695 DOI: 10.1042/BSR20203850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
115 Bai X, Fu R, Duan Z, Wang P, Zhu C, Fan D. Ginsenoside Rk3 alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice. Food Res Int 2021;146:110465. [PMID: 34119248 DOI: 10.1016/j.foodres.2021.110465] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
116 Bilello J, Okereke I. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal Microbiome. Biomedicines 2021;9:617. [PMID: 34072493 DOI: 10.3390/biomedicines9060617] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
117 Knudsen JK, Bundgaard-Nielsen C, Hjerrild S, Nielsen RE, Leutscher P, Sørensen S. Gut microbiota variations in patients diagnosed with major depressive disorder-A systematic review. Brain Behav 2021;11:e02177. [PMID: 34047485 DOI: 10.1002/brb3.2177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
118 Saeed M, Shoaib A, Kandimalla R, Javed S, Almatroudi A, Gupta R, Aqil F. Microbe-based therapies for colorectal cancer: Advantages and limitations. Semin Cancer Biol 2021:S1044-579X(21)00148-6. [PMID: 34020027 DOI: 10.1016/j.semcancer.2021.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
119 Mueller NT, Differding MK, Zhang M, Maruthur NM, Juraschek SP, Miller ER 3rd, Appel LJ, Yeh HC. Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial. Diabetes Care 2021:dc202257. [PMID: 34006565 DOI: 10.2337/dc20-2257] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
120 Markowski MC, Sfanos KS. The interplay of microbiota and hormone regulation in men with prostate cancer. Prostate Cancer Prostatic Dis 2021. [PMID: 34007013 DOI: 10.1038/s41391-021-00385-6] [Reference Citation Analysis]
121 Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
122 Salosensaari A, Laitinen V, Havulinna AS, Meric G, Cheng S, Perola M, Valsta L, Alfthan G, Inouye M, Watrous JD, Long T, Salido RA, Sanders K, Brennan C, Humphrey GC, Sanders JG, Jain M, Jousilahti P, Salomaa V, Knight R, Lahti L, Niiranen T. Taxonomic signatures of cause-specific mortality risk in human gut microbiome. Nat Commun 2021;12:2671. [PMID: 33976176 DOI: 10.1038/s41467-021-22962-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
123 Tassoulas LJ, Robinson A, Martinez-Vaz B, Aukema KG, Wackett LP. Filling in the Gaps in Metformin Biodegradation: a New Enzyme and a Metabolic Pathway for Guanylurea. Appl Environ Microbiol 2021;87:e03003-20. [PMID: 33741630 DOI: 10.1128/AEM.03003-20] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
124 Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl Environ Microbiol 2021;87:e00395-21. [PMID: 33741632 DOI: 10.1128/AEM.00395-21] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
125 Vuong HE, Coley EJL, Kazantsev M, Cooke ME, Rendon TK, Paramo J, Hsiao EY. Interactions between maternal fluoxetine exposure, the maternal gut microbiome and fetal neurodevelopment in mice. Behav Brain Res 2021;410:113353. [PMID: 33979656 DOI: 10.1016/j.bbr.2021.113353] [Reference Citation Analysis]
126 Pot B, Vandenplas Y. Factors that influence clinical efficacy of live biotherapeutic products. Eur J Med Res 2021;26:40. [PMID: 33947466 DOI: 10.1186/s40001-021-00509-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
127 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
128 Gou W, Fu Y, Yue L, Chen GD, Cai X, Shuai M, Xu F, Yi X, Chen H, Zhu Y, Xiao ML, Jiang Z, Miao Z, Xiao C, Shen B, Wu X, Zhao H, Ling W, Wang J, Chen YM, Guo T, Zheng JS. Gut microbiota, inflammation, and molecular signatures of host response to infection. J Genet Genomics 2021:S1673-8527(21)00094-1. [PMID: 34257044 DOI: 10.1016/j.jgg.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
129 Gawlik-Kotelnicka O, Strzelecki D. Probiotics as a Treatment for "Metabolic Depression"? A Rationale for Future Studies. Pharmaceuticals (Basel) 2021;14:384. [PMID: 33924064 DOI: 10.3390/ph14040384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 Li R, Boer CG, Oei L, Medina-Gomez C. The Gut Microbiome: a New Frontier in Musculoskeletal Research. Curr Osteoporos Rep 2021;19:347-57. [PMID: 33864574 DOI: 10.1007/s11914-021-00675-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
131 Lepczyńska M, Dzika E, Chen W, Lu CY. Influence of Proton Pump Inhibitors and Histamine Receptor 2 Antagonists on Blastocystis ST3 and Selected Microorganisms of Intestinal Microbiota In Vitro. Clin Transl Gastroenterol 2021;12:e00325. [PMID: 33835078 DOI: 10.14309/ctg.0000000000000325] [Reference Citation Analysis]
132 Pancu DF, Scurtu A, Macasoi IG, Marti D, Mioc M, Soica C, Coricovac D, Horhat D, Poenaru M, Dehelean C. Antibiotics: Conventional Therapy and Natural Compounds with Antibacterial Activity-A Pharmaco-Toxicological Screening. Antibiotics (Basel) 2021;10:401. [PMID: 33917092 DOI: 10.3390/antibiotics10040401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
133 Lengvenyte A, Strumila R, Maimoun L, Seneque M, Olié E, Lefebvre P, Renard E, Courtet P, Guillaume S. A specific association between laxative misuse and suicidal behaviours in patients with anorexia nervosa and bulimia nervosa. Eat Weight Disord 2021. [PMID: 33797033 DOI: 10.1007/s40519-021-01180-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Parrott JL, Restivo VE, Kidd KA, Zhu J, Shires K, Clarence S, Khan H, Sullivan C, Pacepavicius G, Alaee M. Chronic Embryo-Larval Exposure of Fathead Minnows to the Pharmaceutical Drug Metformin: Survival, Growth, and Microbiome Responses. Environ Toxicol Chem 2021. [PMID: 33788292 DOI: 10.1002/etc.5054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
135 Verburg I, van Veelen HPJ, Waar K, Rossen JWA, Friedrich AW, Hernández Leal L, García-Cobos S, Schmitt H. Effects of Clinical Wastewater on the Bacterial Community Structure from Sewage to the Environment. Microorganisms 2021;9:718. [PMID: 33807193 DOI: 10.3390/microorganisms9040718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Gawlik-Kotelnicka O, Skowrońska A, Margulska A, Czarnecka-Chrebelska KH, Łoniewski I, Skonieczna-Żydecka K, Strzelecki D. The Influence of Probiotic Supplementation on Depressive Symptoms, Inflammation, and Oxidative Stress Parameters and Fecal Microbiota in Patients with Depression Depending on Metabolic Syndrome Comorbidity-PRO-DEMET Randomized Study Protocol. J Clin Med 2021;10:1342. [PMID: 33804999 DOI: 10.3390/jcm10071342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Mehta RS, Kochar BD, Kennelty K, Ernst ME, Chan AT. Emerging approaches to polypharmacy among older adults. Nat Aging 2021;1:347-56. [DOI: 10.1038/s43587-021-00045-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
138 Bai X, Fu R, Duan Z, Liu Y, Zhu C, Fan D. Ginsenoside Rh4 alleviates antibiotic-induced intestinal inflammation by regulating the TLR4-MyD88-MAPK pathway and gut microbiota composition. Food Funct 2021;12:2874-85. [PMID: 33877243 DOI: 10.1039/d1fo00242b] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
139 Zimmermann M, Patil KR, Typas A, Maier L. Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol Syst Biol 2021;17:e10116. [PMID: 33734582 DOI: 10.15252/msb.202010116] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
140 Roy D, Tomo S, Purohit P, Setia P. Microbiome in Death and Beyond: Current Vistas and Future Trends. Front Ecol Evol 2021;9:630397. [DOI: 10.3389/fevo.2021.630397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Spichak S, Bastiaanssen TFS, Berding K, Vlckova K, Clarke G, Dinan TG, Cryan JF. Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease. Neurosci Biobehav Rev 2021;125:698-761. [PMID: 33675857 DOI: 10.1016/j.neubiorev.2021.02.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
142 Wu S, Jiang P, Zhao XM, Chen WH. Treatment regimens may compromise gut-microbiome-derived signatures for liver cirrhosis. Cell Metab 2021;33:455-6. [PMID: 33657385 DOI: 10.1016/j.cmet.2021.02.012] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
143 Navarro-Tapia E, Almeida-Toledano L, Sebastiani G, Serra-Delgado M, García-Algar Ó, Andreu-Fernández V. Effects of Microbiota Imbalance in Anxiety and Eating Disorders: Probiotics as Novel Therapeutic Approaches. Int J Mol Sci 2021;22:2351. [PMID: 33652962 DOI: 10.3390/ijms22052351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
144 Xu H, Ou Z, Zhou Y, Li Y, Huang H, Zhao H, Xu J, Luo M, Zhou Y, Nie Y. Intestinal mucosal microbiota composition of patients with acquired immune deficiency syndrome in Guangzhou, China. Exp Ther Med 2021;21:391. [PMID: 33680113 DOI: 10.3892/etm.2021.9822] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Zhang W, Qu W, Wang H, Yan H. Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress. Transl Psychiatry 2021;11:131. [PMID: 33602895 DOI: 10.1038/s41398-021-01254-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
146 Wilmanski T, Diener C, Rappaport N, Patwardhan S, Wiedrick J, Lapidus J, Earls JC, Zimmer A, Glusman G, Robinson M, Yurkovich JT, Kado DM, Cauley JA, Zmuda J, Lane NE, Magis AT, Lovejoy JC, Hood L, Gibbons SM, Orwoll ES, Price ND. Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab 2021;3:274-86. [PMID: 33619379 DOI: 10.1038/s42255-021-00348-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 81] [Article Influence: 17.0] [Reference Citation Analysis]
147 Jansen VL, Gerdes VE, Middeldorp S, van Mens TE. Gut microbiota and their metabolites in cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2021;35:101492. [PMID: 33642219 DOI: 10.1016/j.beem.2021.101492] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
148 Qi C, Wang P, Fu T, Lu M, Cai Y, Chen X, Cheng L. A comprehensive review for gut microbes: technologies, interventions, metabolites and diseases. Brief Funct Genomics 2021;20:42-60. [PMID: 33554248 DOI: 10.1093/bfgp/elaa029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
149 Gawlik-Kotelnicka O, Strzelecki D. Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap. Life (Basel) 2021;11:117. [PMID: 33557031 DOI: 10.3390/life11020117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
150 Knudsen JK, Leutscher P, Sørensen S. Gut Microbiota in Bone Health and Diabetes. Curr Osteoporos Rep 2021;19:462-79. [PMID: 33523423 DOI: 10.1007/s11914-020-00629-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
151 Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Transl Res 2021;233:144-61. [PMID: 33515779 DOI: 10.1016/j.trsl.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
152 Marco ML, Hill C, Hutkins R, Slavin J, Tancredi DJ, Merenstein D, Sanders ME. Should There Be a Recommended Daily Intake of Microbes? J Nutr 2020;150:3061-7. [PMID: 33269394 DOI: 10.1093/jn/nxaa323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
153 Yao ZD, Cao YN, Peng LX, Yan ZY, Zhao G. Coarse Cereals and Legume Grains Exert Beneficial Effects through Their Interaction with Gut Microbiota: A Review. J Agric Food Chem 2021;69:861-77. [PMID: 33264009 DOI: 10.1021/acs.jafc.0c05691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
154 Simon-Soro A, Kim D, Li Y, Liu Y, Ito T, Sims KR Jr, Benoit DSW, Bittinger K, Koo H. Impact of the repurposed drug thonzonium bromide on host oral-gut microbiomes. NPJ Biofilms Microbiomes 2021;7:7. [PMID: 33483519 DOI: 10.1038/s41522-020-00181-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Brand EC, Klaassen MAY, Gacesa R, Vich Vila A, Ghosh H, de Zoete MR, Boomsma DI, Hoentjen F, Horjus Talabur Horje CS, van de Meeberg PC, Willemsen G, Fu J, Wijmenga C, van Wijk F, Zhernakova A, Oldenburg B, Weersma RK; Dutch TWIN-IBD consortium and the Dutch Initiative on Crohn and Colitis. Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients. Gastroenterology 2021;160:1970-85. [PMID: 33476671 DOI: 10.1053/j.gastro.2021.01.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
156 Naqvi S, Asar TO, Kumar V, Al-Abbasi FA, Alhayyani S, Kamal MA, Anwar F. A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother 2021;134:111156. [PMID: 33401080 DOI: 10.1016/j.biopha.2020.111156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
157 Fritsche E, Haarmann-Stemmann T, Kapr J, Galanjuk S, Hartmann J, Mertens PR, Kämpfer AAM, Schins RPF, Tigges J, Koch K. Stem Cells for Next Level Toxicity Testing in the 21st Century. Small 2021;17:e2006252. [PMID: 33354870 DOI: 10.1002/smll.202006252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
158 Damhorst GL, Adelman MW, Woodworth MH, Kraft CS. Current Capabilities of Gut Microbiome-Based Diagnostics and the Promise of Clinical Application. J Infect Dis 2021;223:S270-5. [PMID: 33330938 DOI: 10.1093/infdis/jiaa689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
159 Balvers M, van den Born BH, Levin E, Nieuwdorp M. Impact drugs targeting cardiometabolic risk on the gut microbiota. Curr Opin Lipidol 2021;32:38-54. [PMID: 33332920 DOI: 10.1097/MOL.0000000000000727] [Reference Citation Analysis]
160 Dalhoff A. Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets? Infection 2021;49:569-89. [PMID: 33325009 DOI: 10.1007/s15010-020-01547-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Barton W, Cronin O, Garcia-Perez I, Whiston R, Holmes E, Woods T, Molloy CB, Molloy MG, Shanahan F, Cotter PD, O'Sullivan O. The effects of sustained fitness improvement on the gut microbiome: A longitudinal, repeated measures case-study approach. Transl Sports Med 2021;4:174-92. [PMID: 34355132 DOI: 10.1002/tsm2.215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Pellanda P, Ghosh TS, O'Toole PW. Understanding the impact of age-related changes in the gut microbiome on chronic diseases and the prospect of elderly-specific dietary interventions. Curr Opin Biotechnol 2021;70:48-55. [PMID: 33279732 DOI: 10.1016/j.copbio.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
163 Jia R, Li Z, Wu J, Ou Z, Liao B, Sun B, Lin L, Zhao M. Mitigation mechanisms of Hizikia fusifarme polysaccharide consumption on type 2 diabetes in rats. International Journal of Biological Macromolecules 2020;164:2659-70. [DOI: 10.1016/j.ijbiomac.2020.08.154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
164 Rosener B, Sayin S, Oluoch PO, García González AP, Mori H, Walhout AJ, Mitchell A. Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenorhabditis elegans host. Elife 2020;9:e59831. [PMID: 33252330 DOI: 10.7554/eLife.59831] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
165 Donati Zeppa S, Agostini D, Piccoli G, Stocchi V, Sestili P. Gut Microbiota Status in COVID-19: An Unrecognized Player? Front Cell Infect Microbiol. 2020;10:576551. [PMID: 33324572 DOI: 10.3389/fcimb.2020.576551] [Cited by in Crossref: 16] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
166 Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Nutritional and therapeutic approaches for protecting human gut microbiota from psychotropic treatments. Prog Neuropsychopharmacol Biol Psychiatry 2021;108:110182. [PMID: 33232785 DOI: 10.1016/j.pnpbp.2020.110182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
167 Madsen MSA, Grønlund RV, Eid J, Christensen-Dalsgaard M, Sommer M, Rigbolt K, Madsen MR, Jelsing J, Vrang N, Hansen HH, Mikkelsen M. Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice. Biomed Pharmacother 2021;133:110966. [PMID: 33171401 DOI: 10.1016/j.biopha.2020.110966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
168 Stencel A. Do seasonal microbiome changes affect infection susceptibility, contributing to seasonal disease outbreaks? Bioessays 2021;43:e2000148. [PMID: 33165975 DOI: 10.1002/bies.202000148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Morais LH, Schreiber HL 4th, Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders. Nat Rev Microbiol 2021;19:241-55. [PMID: 33093662 DOI: 10.1038/s41579-020-00460-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 244] [Article Influence: 27.5] [Reference Citation Analysis]
170 Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep 2020;10:17878. [PMID: 33087796 DOI: 10.1038/s41598-020-74934-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
171 Wong SH, Yu J. Proton-pump inhibitor use before fecal microbiota transplant: A wonder drug, a necessary evil, or a needless prescription? J Gastroenterol Hepatol 2020;35:913-4. [PMID: 32537754 DOI: 10.1111/jgh.15103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
172 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Haga SB. Individualizing pharmacogenomic test results in the context of the microbiome. Per Med 2020;17:459-68. [PMID: 33026284 DOI: 10.2217/pme-2020-0077] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Castaneda M, Strong JM, Alabi DA, Hernandez CJ. The Gut Microbiome and Bone Strength. Curr Osteoporos Rep 2020;18:677-83. [PMID: 33030683 DOI: 10.1007/s11914-020-00627-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
175 Dash HR, Das S. Thanatomicrobiome and epinecrotic community signatures for estimation of post-mortem time interval in human cadaver. Appl Microbiol Biotechnol 2020;104:9497-512. [PMID: 33001249 DOI: 10.1007/s00253-020-10922-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
176 Coman V, Vodnar DC. Gut microbiota and old age: Modulating factors and interventions for healthy longevity. Exp Gerontol 2020;141:111095. [PMID: 32979504 DOI: 10.1016/j.exger.2020.111095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
177 Chambers LM, Kuznicki M, Yao M, Chichura A, Gruner M, Reizes O, Debernardo R, Rose PG, Michener C, Vargas R. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer. Gynecol Oncol 2020;159:699-705. [PMID: 32950250 DOI: 10.1016/j.ygyno.2020.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
178 Feng W, Liu J, Ao H, Yue S, Peng C. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs. Theranostics 2020;10:11278-301. [PMID: 33042283 DOI: 10.7150/thno.47289] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
179 Proffitt C, Bidkhori G, Moyes D, Shoaie S. Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions. Microorganisms 2020;8:E1381. [PMID: 32916966 DOI: 10.3390/microorganisms8091381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
180 Seeman MV. The gut microbiome and antipsychotic treatment response. Behav Brain Res 2021;396:112886. [PMID: 32890599 DOI: 10.1016/j.bbr.2020.112886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
181 Mukherji R, Weinberg BA. The gut microbiome and potential implications for early-onset colorectal cancer. Colorectal Cancer 2020;9:CRC25. [DOI: 10.2217/crc-2020-0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
182 Shi XJ, Wei Y, Ji B. Systems Biology of Gastric Cancer: Perspectives on the Omics-Based Diagnosis and Treatment.Front Mol Biosci. 2020;7:203. [PMID: 33005629 DOI: 10.3389/fmolb.2020.00203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
183 Wang C, Zhao J, Zhang H, Lee YK, Zhai Q, Chen W. Roles of intestinal bacteroides in human health and diseases. Crit Rev Food Sci Nutr 2020;:1-19. [PMID: 32757948 DOI: 10.1080/10408398.2020.1802695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
184 Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome. Gut 2020;69:1510-9. [PMID: 32409589 DOI: 10.1136/gutjnl-2019-320204] [Cited by in Crossref: 119] [Cited by in F6Publishing: 122] [Article Influence: 59.5] [Reference Citation Analysis]
185 Daliri EB, Ofosu FK, Chelliah R, Lee BH, Oh DH. Health Impact and Therapeutic Manipulation of the Gut Microbiome. High Throughput 2020;9:E17. [PMID: 32751130 DOI: 10.3390/ht9030017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
186 Brushett S, Sinha T, Reijneveld SA, de Kroon MLA, Zhernakova A. The Effects of Urbanization on the Infant Gut Microbiota and Health Outcomes. Front Pediatr 2020;8:408. [PMID: 32903831 DOI: 10.3389/fped.2020.00408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
187 Stacchiotti V, Rezzi S, Eggersdorfer M, Galli F. Metabolic and functional interplay between gut microbiota and fat-soluble vitamins. Crit Rev Food Sci Nutr 2020;:1-22. [PMID: 32715724 DOI: 10.1080/10408398.2020.1793728] [Cited by in Crossref: 8] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
188 Horvath A, Bausys A, Sabaliauskaite R, Stratilatovas E, Jarmalaite S, Schuetz B, Stiegler P, Bausys R, Stadlbauer V, Strupas K. Distal Gastrectomy with Billroth II Reconstruction is Associated with Oralization of Gut Microbiome and Intestinal Inflammation: A Proof-of-Concept Study. Ann Surg Oncol. 2021;28:1198-1208. [PMID: 32504369 DOI: 10.1245/s10434-020-08678-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
189 Przewłócka K, Folwarski M, Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Kaczor JJ. Gut-Muscle AxisExists and May Affect Skeletal Muscle Adaptation to Training. Nutrients 2020;12:E1451. [PMID: 32443396 DOI: 10.3390/nu12051451] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
190 Iruzubieta P, Medina JM, Fernández-López R, Crespo J, de la Cruz F. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression. J Clin Med 2020;9:E1369. [PMID: 32392712 DOI: 10.3390/jcm9051369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
191 Ceccarani C, Bassanini G, Montanari C, Casiraghi MC, Ottaviano E, Morace G, Biasucci G, Paci S, Borghi E, Verduci E. Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients. Metabolites 2020;10:E133. [PMID: 32235604 DOI: 10.3390/metabo10040133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
192 Madan S, Mehra MR. Gut dysbiosis and heart failure: navigating the universe within. Eur J Heart Fail 2020;22:629-37. [DOI: 10.1002/ejhf.1792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
193 [DOI: 10.1101/2020.04.22.20076091] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Reference Citation Analysis]